Phil Skolnick - 05 Jan 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Chief Scientific Officer
Signature
/s/ Phil Skolnick
Issuer symbol
N/A
Transactions as of
05 Jan 2023
Net transactions value
-$28,704
Form type
4
Filing time
05 Jan 2023, 15:56:03 UTC
Previous filing
15 Jul 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale $28,704 -1,421 -6% $20.20 22,397 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.